155 related articles for article (PubMed ID: 1854459)
1. Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats.
Fenoy FJ; Milicic I; Smith RD; Wong PC; Timmermans PB; Roman R
Am J Hypertens; 1991 Apr; 4(4 Pt 2):321S-326S. PubMed ID: 1854459
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacology of DuP 753.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150
[TBL] [Abstract][Full Text] [Related]
4. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
Brännström K; Morsing P; Arendshorst WJ
Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
[TBL] [Abstract][Full Text] [Related]
6. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.
Yang RH; Jin H; Wyss JM; Oparil S
Hypertension; 1992 May; 19(5):475-81. PubMed ID: 1568766
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
[TBL] [Abstract][Full Text] [Related]
8. Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats.
Yang RH; Jin H; Chen SJ; Wyss JM; Oparil S
Hypertension; 1992 Dec; 20(6):755-62. PubMed ID: 1452291
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
10. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
12. Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats.
Kline RL; Liu F
Hypertension; 1994 Oct; 24(4):467-73. PubMed ID: 8088913
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
Vyas SJ; Jackson EK
J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
[TBL] [Abstract][Full Text] [Related]
14. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
[TBL] [Abstract][Full Text] [Related]
15. Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogs.
Bovee KC; Wong PC; Timmermans PB; Thoolen MJ
Am J Hypertens; 1991 Apr; 4(4 Pt 2):327S-333S. PubMed ID: 1854460
[TBL] [Abstract][Full Text] [Related]
16. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
[TBL] [Abstract][Full Text] [Related]
17. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
Fenoy FJ; Scicli G; Carretero O; Roman RJ
Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
[TBL] [Abstract][Full Text] [Related]
18. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
Fenoy FJ; Milicic I; Mistry M; Mecca TE; Roman RJ
J Pharmacol Exp Ther; 1992 May; 261(2):470-5. PubMed ID: 1578362
[TBL] [Abstract][Full Text] [Related]
19. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril.
Harrap SB; Nicolaci JA; Doyle AE
Clin Exp Pharmacol Physiol; 1986; 13(11-12):753-65. PubMed ID: 3030586
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
Kvam FI; Ofstad J; Iversen BM
Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
